Skip to main content
Log in

Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy

  • Research Article
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Hunan province located in the south of China has a high incidence of haemoglobinopathies. In the present study, we surveyed the accurate population frequency data of the local population in Changsha city of Hunan province in China. The data includes the carrying rate, gene mutation types and their distribution features for thalassaemia. In total, 7500 consecutive samples from five geographical areas of Changsha were analysed for both haematological and molecular parameters. There was a high prevalence of carriers of \(\upalpha \)-thalassaemia (2.57%), \(\upbeta \)-thalassaemia (1.9%) and both \(\upalpha \)-thalassaemia and \(\upbeta \)-thalassaemia (0.08%). Overall, 4.54% of the population in this area represented heterozygous carriers of \(\upalpha \)-thalassaemia and \(\upbeta \)-thalassaemia. The mutation spectrum of \(\upalpha \)-thalassaemia and \(\upbeta \)-thalassaemia and its haematological characterization were fully described for this area. The present study is the first to report the prevalence of thalassaemia in Hunan province population. Both \(\upalpha \)-thalassaemia and \(\upbeta \)-thalassaemia carriers are widely distributed in Changsha. The knowledge gained from the present study will allow for an estimation of the projected number of pregnant women at risk for thalassaemia, and the design of a screening strategy for the control of thalassaemia in Changsha.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Atanasovska B., Bozhinovski G., Chakalova L., Kocheva S., Karanfilski O. and Plaseska-Karanfiska D. 2012 Molecular diagnostics of \(\beta \)-thalassemia. Balkan J. Med. Genet. 15, 61–65.

  • Bank A. 2015 The thalassemia syndromes. Blood 51, 369–384.

  • Cai P., Jiang X. U. and Yan H. U. 2010 An epidemiological investigation and management of the first a/h1n1 (swine flu) outbreak case in college, in sichuan. Mod. Prev. Med. 120, 83–84.

  • Chatterjee R., Bajoria R., Shah F. T., Porter J. B. and Fedele S. 2014 High index of suspicion for early diagnosis of alendronate-induced stage zero osteonecrosis of jaw in thalassaemia major. Br. J. Haematol. 166, 292–294.

  • Chen F. E., Ooi C., Ha S. Y., Cheung B. M. Y., Todd D., Liang R. et al. 2000 Genetic and clinical features of hemoglobin H disease in Chinese patients. N. Engl. J. Med. 343, 544–550.

  • Chen M., Loh S. F., Yu S. L., Nair S., Tan H. H., Nadarajah S. et al. 2015 Rapid and reliable preimplantation genetic diagnosis of common Hb Bart’s hydrops fetalis syndrome and Hb H disease determinants using an enhanced single-tube decaplex PCR assay. Am. J. Hematol. 90, E194–E196.

  • Colah R., Gorakshakar A. and Nadkarni A. 2010 Global burden, distribution and prevention of \(\beta \)-thalassemias and hemoglobin E disorders. Expert Rev. Hematol. 3, 103–117.

  • Daniel Y. 2007 Haemoglobinopathy diagnostic tests: blood counts, sickle solubility test, haemoglobin electrophoresis and high-performance liquid chromatography. In Practical management of haemoglobinopathies (ed. I. E. Okpala), pp. 10–19. Blackwell Publishing Ltd, Oxford, UK (doi: 10.1002/9780470988398.ch2).

  • Higgs D. R. 1993 The thalassaemia syndromes. Q. J. Med. 86, 559–564.

  • Huang S. W., Liu X. M., Li G. F., Su L., Wu X. and Wang R. L. 2013 Spectrum of \(\beta \)-thalassemia mutations in Guizhou Province, PR China, including first observation of codon 121 (GAA\({>}\)TAA) in Chinese population. Clin. Biochem. 46, 1865–1868.

  • Huang Y., Qu X., Zhang L., Yu Y. and Wu S. 2006 The incidence of \(\beta \)-thalassemia and analysis of \(\beta \)-thalassemia gene mutation in children in guangzhou region. J. Clin. Hematol. 6, 355–357.

  • Jia S. Q., Li J., Mo Q. H., Liao C., Li L. Y. and Xu X. M. 2004 Alpha0 thalassaemia \(\beta \)-thalassemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes. J. Clin. Pathol. 57, 164–167.

  • Joly P., Pondarre C. and Badens C. 2014 Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects. Ann. Biol. Clin. (Paris) 72, 639–668.

  • Li M., Nie L. P., Tao X. M., Li Y. Z., Chen X. Z., Zheng G. Q. et al. 2005 Frequency and genotypes of thalassemia in Shenzhen area. J. Trop. Med. 3, 301–303.

  • Liebhaber S. A. and Kan Y. W. 1983 alpha-thalassemia caused by an unstable alpha-globin mutant. J. Clin. Invest. 71, 461–466.

  • Piel F. B. and Weatherall D. J. 2014 The \(\alpha \)-thalassemias. N. Engl. J. Med. 371, 1908–1916.

  • Sabath D. E., Bender M. A., Sankaran V. G., Vamos E., Kentsis A., Yi H. S. et al. 2015 Characterization of deletions of the HBA and HBB loci by array comparative genomic hybridization. J. Mol. Diagn. 18, 92–99.

  • Shi X. N., Chu J. Y. and Yang Z. Q. 2011 Genotype distribution and characteristics of beta-thalassemia of different province in China. Med. Recapitulate 4, 495–497.

  • Van de Velde H., Georgiou I., De Rycke M., Schots R., Sermon K., Lissens W. et al. 2004 Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum. Reprod. 19, 700–708.

  • Yang K. G., Kutlar F., George E., Wilson J. B., Kutlar A., Stoming T. A. et al. 1989 Molecular characterization of \(\beta \)-thalassemia mutations in malay patients with HbE-\(\beta \)-globi–gene mutations in Malay patients with HbE-\(\beta \)-thalassaemia and thalassaemia major. Br. J. Haematol. 72, 73–80.

  • Yin X. L., Wu Z. K., He Y. Y., Zhou T. H., Zhou Y. L. and Zhang X. H. 2011 Treatment and complications of thalassemia major in Guangxi, Southern China. Pediatr. Blood Cancer 57, 1174–1178.

  • Xiong F., Sun M., Zhang X., Cai R., Zhou Y., Lou J. et al. 2010 Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang autonomous region of southern China. Clin. Genet. 78, 139–148.

  • Xu X. M., Zhou Y. Q., Luo G. X., Liao C., Zhou M., Chen P. Y. et al. 2004 The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J. Clin. Pathol. 57, 517–522.

  • Zeng Y. and Huang S. 2001 The studies of hemoglobinopathies and thalassemia in China-the experiences in Shanghai Institute of Medical Genetics. Clin. Chim. Acta 313, 107–111.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun He.

Additional information

He J., Zeng H., Zhu L., Li H., Shi L. and Hu L. 2017 Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy. J. Genet. 96, xx–xx

Corresponding editor: Rajiva Raman

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, J., Zeng, H., Zhu, L. et al. Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy. J Genet 96, 327–332 (2017). https://doi.org/10.1007/s12041-017-0779-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-017-0779-6

Keywords

Navigation